Navigation Links
Medivation in Medical News

Medivation Announces Second Quarter 2009 Financial Results Teleconference and Webcast on August 5, 2009

...n the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...

Medivation to Present at 8th Annual Needham Life Sciences Conference

...e Hotel. Dr. Hung will provide an overview of medivation and its clinical development programs for Dimebon ... days following the live presentation. About medivation Medivation, Inc. is a biopharmaceutical com...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation Announces Offering of 2,750,000 Shares of Common Stock

...ment (telephone number 718-242-8002). About medivation Medivation, Inc. is a biopharmaceutical compan...s release contains "forward-looking statements" of medivation within the meaning of the federal securities laws....ts that speak only as of the date of this release. medivation undertakes no obligation to update publicly any fo...

Medivation Announces Upcoming Presentation of New MDV3100 Data in Patients With Advanced Prostate Cancer at 45th American Society of Clinical Oncology Annual Meeting

...rease global access to cutting-edge science. medivation recently received written permission from the U.S....reatment options and a poor prognosis. About medivation Medivation, Inc. is a biopharmaceutical company...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference

...ew York. Dr. Hung will provide an overview of medivation and its clinical development programs at 10:30 a.m... days following the live presentation. About medivation Medivation, Inc. is a biopharmaceutical compan...es for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation Reports First Quarter 2009 Financial Results and Provides Corporate Update

...st quarter of 2009, the true-up payment payable to medivation was $5.8 million. medivation presents these cost-sharing true-up payments in th...expense line of its statement of operations. medivation reported a net loss for the quarter ended March 31...

New Prostate Cancer Drug May Hold Promise

... he said. Based on those results, Scher said, an application for a large-scale trial has been submitted to the U.S. Food and Drug Administration by medivation Inc., a California-based biopharmaceutical company that has licensed the drug, now called MDV3100. The hope is that the trial will lead to FDA approva...

Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer

...he androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...

Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009

...on the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical company...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...

Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients

...o the event listing in the Investor section of the medivation website. A replay of the webcast will be availabl...on the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...
Medivation in Medical Technology

Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease

--New 12-month study broadens Phase 3 clinical program to further evaluate the benefits of Dimebon in Alzheimer's Disease-- NEW YORK and SAN FRANCISCO, April 15 /PRNewswire-FirstCall/ -- Pfizer (NYSE: PFE ) and Medivation, Inc. (Nasdaq: MDVN ) today announced the initiation of a 12-mont...

Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients

...ated at doses up to and including 240 mg/day. medivation plans to initiate a pivotal Phase 3 clinical trial...he androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients

...e androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation entered into a global agreement with Pfizer Inc to...

Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease

...of Action In a podium presentation at ICAD 2008, medivation presented new data on Dimebon's novel mitochondria...ochondrial mechanism of action. On July 7, 2008, medivation announced positive safety and efficacy results fro...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease

...rates through a novel mitochondrial mechanism of action. On July 7, 2008, medivation announced positive safety and efficacy results from its Phase 2 trial of Di...gs to treat serious diseases for which there are limited treatment options. medivation aims to transform the treatment of these diseases and offer hope to critica...

Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease

...novel mitochondrial mechanism of action. Teleconference/Webcast Details medivation will host a teleconference at 5:00 p.m. Eastern Daylight Time today. To par...gs to treat serious diseases for which there are limited treatment options. medivation aims to improve the treatment of these diseases and offer hope to criticall...

Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease

...pment of novel small molecule drugs to treat serious diseases of the central nervous system and cancers for which there are limited treatment options. medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical d...

Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimer's Disease

...-6386). Results of First Pivotal Phase 3 Trial medivation previously announced results from its first pivota...rough a novel mitochondrial mechanism of action. medivation is also evaluating Dimebon in an ongoing Phase 2 c...ers for which there are limited treatment options. medivation aims to revolutionize the treatment of these disea...

Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting

...e patients and are also exploring higher doses." medivation expects to complete the study, and report final to...e results, in 2008. If these results are positive, medivation expects to seek U.S. Food and Drug Administration ...ers for which there are limited treatment options. medivation aims to revolutionize the treatment of these disea...

Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting

...ity, pharmacokinetics, effects on serum PSA levels and disease progression. medivation expects to complete the study and report final top-line results in 2008. ...l nervous system and cancers for which there are limited treatment options. medivation aims to revolutionize the treatment of these diseases and offer hope to cri...
Medivation in Biological News

New drug shows promise in treating drug-resistant prostate cancer

...pounds were licensed by the pharmaceutical company medivation Inc., which chose to test MDV3100 in clinical tria...e Food and Drug Administration has agreed to allow medivation to begin what Jung described as "the pivotal Phase...eptors. The promising laboratory studies led medivation to license the drugs for commercial development. ...

New medications show promise in treating drug-resistant prostate cancer

...cancer cells. The new compounds manufactured by the pharmaceutical company medivation and known as MDV3100 and RD162 appear to work well even in prostate cells ...eptor is present, Sawyers explained. The promising laboratory studies led medivation to license the drugs for commercial development, said Sawyers, who serves a...
Medivation in Biological Technology

Medivation Completes Enrollment in Confirmatory, Pivotal Phase 3 'CONNECTION' Trial of Dimebon in Patients With Alzheimer's Disease

...ngton disease, a Phase 2 study has been completed. medivation and Pfizer expect to initiate a Phase 3 trial this... well as delusions or hallucinations. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation Announces Pricing of Public Offering

...ment (telephone number 718-242-8002). About medivation Medivation, Inc. is a biopharmaceutical com...s release contains "forward-looking statements" of medivation within the meaning of the federal securities laws....ts that speak only as of the date of this release. medivation undertakes no obligation to update publicly any fo...

Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009

...on the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...

Medivation Announces Upcoming Scientific Presentations at Medical Conferences

...om currently available AD medications. About medivation Medivation, Inc. is a biopharmaceutical compan...es for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...

Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update

...th quarter of 2008, the true-up payment payable to medivation was $3.5 million. medivation presents these cost-sharing true-up payments in th... expense line of its statement of operations. medivation reported a net loss for the quarter ended December...

Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients

...CO's 2009 Genitourinary Cancers Symposium - - medivation to Host Conference Call and Webcast Presentation w...state cancer, I am enthusiastic about working with medivation to advance MDV3100 into Phase 3 clinical developme...o the event listing in the Investor section of the medivation website. A replay of the webcast will be availabl...

Medivation Presents New Data on Dimebon's Novel Mechanism of Action

... is planned in Huntington's disease. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation entered into a global agreement with Pfizer Inc to...

Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference

...ays following the live presentation. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation entered into a global agreement with Pfizer Inc to...

Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update

...s diseases. Under the terms of the agreement, medivation has received an up-front cash payment of $225 ...um tolerated dose (MTD) has not been reached. -- medivation expects to seek FDA agreement to begin a pivotal P... 2009. Third Quarter 2008 Financial Results medivation reported a net loss for the quarter ended Septembe...

Medivation Announces Third Quarter 2008 Teleconference and Webcast on November 10, 2008

...utical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical devel...
Other Tags
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... Refining convenience stores throughout the Southwest, including Giant, Mustang, Sun Dial and ... mobile program, surpassing their original 2015 fundraising goal by nearly $100,000, to ...
(Date:7/7/2015)... ... July 07, 2015 , ... A ... facial rejuvenation that have emerged about Hillary Clinton. Two plastic surgeons consulted by ... more youthful than she has in some time and speculate that she might ...
(Date:7/7/2015)... ... ... Quadrino Law Group is pleased to announce the relocation of the firm's headquarters to ... is a state of the art building, located with easy access to New York ... said, "We are pleased to service our clients from such a premier location and ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Safe Catch is ... single fish for mercury. Albertsons, Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market ... , “We developed the technology to test every fish for mercury,” said Safe Catch ...
(Date:7/7/2015)... ... July 07, 2015 , ... Parents and guardians of teenagers or young ... an open-ended holistic treatment center for drug and alcohol abuse located in Southwest Michigan. ... Research has shown a significant increase in the “club drug” use among high school ...
Breaking Medicine News(10 mins):Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2
(Date:6/26/2015)... SPRINGVILLE, Utah , June 26, 2015 ATL ... assemblies and devices with specialties in single use solutions, headquartered ... acquisition of MedConx, Inc. (a California ... , and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing ...
(Date:6/24/2015)... , June 24, 2015 This report ... over the next six years. It contains an analysis ... industry, along with their impact from the short, medium, ... also discusses the industry, market, and technology trends that ... the need of concerned authorities to efficiently manage the ...
(Date:6/23/2015)... , June 22, 2015 ... the addition of the "Body-Worn Temperature Sensors ... Trends and Forecast 2014 - 2020" report ... strategic analysis of the global body-worn temperature sensors ... been segmented on the basis of types, care ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
Other Contents